Biotech companies are spending billions to perfect chemical formulas, only to be tripped up by the one variable they forgot ...
Australian pharmaceutical and biotechnology start-ups are already looking to take their investments to jurisdictions ...
A bill before Congress would amend the COINS Act, which restricts American investment in sensitive technologies abroad, to include licensing Chinese biotech. Some want the Food and Drug Administration ...
When I first saw the AdCom briefing documents for Legend Biotech’s (LEGN) and Johnson & Johnson’s (JNJ) Carvykti, I thought the stock would surely plunge. But that is not what happened and there was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results